Tegaserod (Zelnorm) safety profile in pediatric patients

被引：0

|

作者：

Har, Aileen F. ^{[1
]}

Steffen, Rita ^{[1
]}

Kaplan, Barbara ^{[1
]}

Mahajan, Lori ^{[1
]}

机构：

[1] Cleveland Clin, Cleveland, OH 44106 USA

来源：

AMERICAN JOURNAL OF GASTROENTEROLOGY | 2007年 / 102卷

关键词：

D O I：

10.14309/00000434-200709002-01041

中图分类号：

R57 [消化系及腹部疾病];

学科分类号：

摘要：

1041

引用

收藏

页码：S500 / S500

页数：1

相关论文

共 50 条

[1] Tegaserod (Zelnorm) Returns
不详
MEDICAL LETTER ON DRUGS AND THERAPEUTICS, 2019, 61 (1571): : 72 - 72
[2] Tegaserod (Zelnorm) withdrawn
不详
MEDICAL LETTER ON DRUGS AND THERAPEUTICS, 2007, 49 (1260): : 40 - 40
[3] Tegaserod maleate (zelnorm) for IBS with constipation
不详
MEDICAL LETTER ON DRUGS AND THERAPEUTICS, 2002, 44 (1139): : 79 - 80
[4] Case History on Tegaserod (Zelnorm®/Zelmac®)
Giger, Rudolf
Mattes, Henri
Pfannkuche, Hans-Juergen
ANNUAL REPORTS IN MEDICINAL CHEMISTRY, VOL 42, 2007, 42 : 195 - +
[5] Tegaserod (Zelnorm) for Irritable Bowel Syndrome
Deyoung, GR
AMERICAN FAMILY PHYSICIAN, 2004, 69 (02) : 363 - 364
[6] Tegaserod (Zelnorm) for the treatment of constipation in Parkinson's disease
Sullivan, KL
Staffetti, JF
Hauser, RA
Dunne, PB
Zesiewicz, TA
MOVEMENT DISORDERS, 2006, 21 (01) : 115 - 116
[7] Review article: the safety profile of tegaserod
Schoenfeld, P
ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2004, 20 : 25 - 30
[8] Tegaserod (Zelnorm) for irritable bowel syndrome: reports of serious diarrhea and intestinal ischemia
Wooltorton, E
CANADIAN MEDICAL ASSOCIATION JOURNAL, 2004, 170 (13) : 1908 - 1908
[9] Tegaserod (Zelnorm) for irritable bowel syndrome (vol 69, pg 363, 2004)
DeYoung, GR
AMERICAN FAMILY PHYSICIAN, 2004, 69 (09) : 2074 - 2074
[10] REEVALUATION OF THE CARDIOVASCULAR SAFETY PROFILE OF TEGASEROD: A REVIEW OF THE CLINICAL DATA
Lacy, Brian E.
Brenner, Darren M.
Chey, William D.
GASTROENTEROLOGY, 2020, 158 (06) : S890 - S890

← 1 2 3 4 5 →